Abstract:Suicide gene therapy has been studied intensively for the treatment of cancer. A limited antitumoral effect was obtained by intratumoral injection of adenovirus harboring Escherichia coli cytosine deaminase gene (AdCD) in tumor-bearing mice followed by continuous administration of 5-fluorocytosine (5FC). To address the drawbacks of the limited potential for the induction of antitumoral immunity by CD suicide gene therapy, we hypothesized that antigen-presenting cells (APCs) might contribute to the efficient induction of an antitumoral immune response in tumor-bearing mice undergoing suicide gene therapy. We preinjected the mice with murine stem cell factor (SCF)-encoding adenovirus (AdSCF) and murine granulocyte-macrophage colony-stimulating factor (GM-CSF)-encoding adenovirus (AdGM-CSF); after 7 days, the mice were inoculated with CT26 colon adenocarcinoma. AdCD was injected intratumorally into tumor-bearing mice followed by 5FC administration. The results showed that AdSCF/AdGM-CSF treatment could increase the number, surface molecule expression, and function of APCs efficiently. A more significant growth inhibition of established tumors and a prolongation of the survival period were observed in tumor-bearing mice after AdSCF/AdGM-CSF pretreatment in combination with AdCD/5FC therapy when compared with mice treated with AdSCF or AdGM-CSF in combination with AdCD/5FC, or AdCD/5FC alone ( P < .01). Cytotoxic T-lymphocyte activity was induced efficiently after the combined therapy, and mRNA of tumor necrosis factor-α, interleukin-4, interferon-γ, and interleukin-2 was present in the tumor mass after combined therapy, suggesting that a more potent antitumoral response was induced by enhanced APCs. Our results demonstrated that AdSCF/AdGM-CSF pretreatment could activate APCs, and that these APCs could present the tumor antigens released from AdCD/5FC-killed tumor cells and activate the antitumoral response of the host, thus increasing the therapeutic efficiency of suicide gene therapy.

A Novel Fusion Suicide Gene Yeast CDglyTK Plays a Role in Radio-Gene Therapy of Nasopharyngeal Carcinoma

Combined Radiation and Suicide Gene Therapy for Nasopharyngeal Carcinoma: in Vitro and in Vivo Models.

The combination of suicide gene therapy and radiation enhances the killing of nasopharyngeal carcinoma xenographs

The Role of Enhanced Radiosensitivity and Tumor-Specific Suicide Gene Vector in Genetherapy of Nasopharyngeal Carcinoma

Radiosensitization by Ycdglytk Fusion Suicide Gene/prodrug System in Human Nasopharyngeal Carcinoma CNE-2 Cell Line

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Tissue Specific Expression of Suicide Genes Delivered by Nanoparticles Inhibits Gastric Carcinoma Growth

Antitumor Effects of Recombinant Vectors Carrying CDglyTK Suicide Gene on Nasopharyngeal Carcinoma Cell in Vitro

Combination gene therapy using VEGF-shRNA and fusion suicide gene yCDglyTK inhibits gastric carcinoma growth.

[In Vitro Experimental Study of Killing Hep-2 Cells of Laryngeal Cancer with Suicide Fusion Gene CDglyTK].

Antitumor Efficiency of the Cytosine Deaminase/5-Fluorocytosine Suicide Gene Therapy System on Malignant Gliomas: an in Vivo Study.

Construction of a Novel Vector Expressing Survivin-shRNA and Fusion Suicide Gene Ycdglytk and Its Application in Inhibiting Proliferation and Migration of Colon Cancer Cells

Novel Non-Viral Vector-Mediated Fusion Suicide Gene Targeted Therapy of Gastric Carcinoma Experimental Study

In Vivo Experimental Study on Nasopharyngeal Carcinoma with Combination of Padkdr-Tk/gcv Suicide Gene Therapysystem and 60co Radiotherapy

Tissue specific cytotoxicity of colon cancer cells mediated by nanoparticle-delivered suicide gene in vitro and in vivo.

Tumor-specific expression of shVEGF and suicide gene as a novel strategy for esophageal cancer therapy.

Construction of Calcium Phosphate Nanoparticles Mediating Fusion Suicide Gene yCDglyTK and its Application in vitro

TK Gene Combined with Mil-2 and Mgm-Csf Genes in Treatment of Gastric Cancer

Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer

Construction of Combination Gene Vector Expressing VEGF-siRNA and Fusion Suicide Gene Ycdglytk and Its Application

Therapeutic Effect of YCD Suicide Gene-Modified Murine P388 Leukemia in Vivo